Announcement PDF 30 November 2020 ASX Market Announcements Office ASX Limited 20 Bridge Street SYDNEY NSW 2000 By Electronic Lodgement Results of 2020 Annual General Meeting The Board of Recce Pharmaceuticals Limited (ASX: RCE) (Company) is pleased to advise that shareholders of the Company passed all resolutions by poll at the 2020 Annual General Meeting held today at 9.00am (Sydney time). In accordance with ASX Listing Rule 3.13.2 and Section 251AA(2) of the Corporations Act, a summary of the proxy votes and the total number of votes cast on each resolution is attached. For more information, please contact the undersigned on (+61 2) 8072 1400. Yours faithfully Alistair McKeough Company Secretary This announcement has been approved for release by Recce Pharmaceuticals Board. Disclosure of Proxy Votes Automic GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 Recce Pharmaceuticals Ltd Annual General Meeting Monday, 30 November 2020 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting. Proxy Votes Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed 1 Adoption of Remuneration Report P 25,753,439 2 Re-election of Dr John Prendergast as Director P 77,819,620 3 Election of Alan W. Dunton, MD as Director P 77,809,620 4 ASX Listing Rule 7.1A Approval of Future Issue of Securities P 75,782,138 5 Ratification of Prior Issue of Shares P 77,672,037 6 Ratification of Prior Issue of Placement Shares P 71,232,375 7 Ratification of Prior Issue of Placement Shares P 71,232,375 FOR AGAINST 23,819,789 1,809,964 92.49% 7.03% 77,657,545 21,285 99.79% 0.03% 77,601,157 47,673 99.73% 0.06% 73,152,711 2,488,637 96.53% 3.28% 77,444,339 92,908 99.71% 0.12% 71,006,167 91,418 99.68% 0.13% 71,006,167 91,418 99.68% 0.13% Poll Results (if applicable) ABSTAIN 4,069,975 7,116 17,116 2,044,598 96,966 5,992,098 6,353,012 PROXY'S DISCRETION FOR AGAINST 123,686 23,968,475 1,809,964 0.48% 92.98% 7.02% 140,790 77,823,335 21,285 0.18% 99.97% 0.03% 160,790 77,786,947 47,673 0.21% 99.94% 0.06% 140,790 73,318,501 2,488,637 0.19% 96.72% 3.28% 134,790 77,604,129 92,908 0.17% 99.88% 0.12% 134,790 71,165,957 91,418 0.19% 99.87% 0.13% 134,790 71,165,957 91,418 0.19% 99.87% 0.13% ABSTAIN 4,069,975 7,116 17,116 2,044,598 96,966 5,992,098 6,353,012 Proxy Votes Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed 8 Ratification of Prior Issue of Options P 77,570,804 9 Adoption of Employee Incentive Plan P 25,884,098 10 Approval of Issue of Shares to Alan W. Dunton, MD, Director of the Company P 25,855,139 11 Approval of Issue of Options to James Graham, Director of the Company P 25,858,908 12 Approval of Issue of Options to Michele Dilizia, Director of the Company P 25,858,908 13 Approval of Issue of Options to John Prendergast, Director of the Company P 25,857,308 14 Approval of Issue of Options to Alan W. Dunton, MD, Director of the Company P 25,853,539 15 Approval of Issue of Options to Justin Ward, Director of the Company P 25,857,308 FOR AGAINST 77,319,340 116,674 99.68% 0.15% 23,189,596 2,561,159 89.59% 9.89% 23,048,595 2,653,097 89.15% 10.26% 23,055,427 2,650,034 89.16% 10.25% 23,050,427 2,655,034 89.14% 10.27% 23,083,827 2,620,034 89.27% 10.13% 23,058,827 2,641,265 89.19% 10.22% 23,053,827 2,650,034 89.16% 10.25% ABSTAIN 255,932 3,924,506 3,809,309 3,805,540 3,805,540 3,807,140 3,810,909 3,966,106 Poll Results (if applicable) PROXY'S DISCRETION FOR AGAINST 134,790 77,479,130 116,674 0.17% 99.85% 0.15% 133,343 23,347,939 2,561,159 0.52% 90.11% 9.89% 153,447 23,227,042 2,653,097 0.59% 89.75% 10.25% 153,447 23,233,874 2,650,034 0.59% 89.76% 10.24% 153,447 23,228,874 2,655,034 0.59% 89.74% 10.26% 153,447 23,262,274 2,620,034 0.59% 89.88% 10.12% 153,447 23,237,274 2,641,265 0.59% 89.79% 10.21% 153,447 23,232,274 2,650,034 0.59% 89.76% 10.24% ABSTAIN 255,932 3,924,506 3,809,309 3,805,540 3,805,540 3,807,140 3,810,909 3,966,106